Spots Global Cancer Trial Database for Familial Pancreatic Cancer PROPHilation Program in Italy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Familial Pancreatic Cancer PROPHilation Program in Italy

Official Title: Standardised Genetic Profiling of Subjects Belonging to the Italian Multicenter Registry of Prospective Surveillance of Subjects at Genetic Risk of Pancreatic Cancer

Study ID: NCT05724992

Conditions

Candidates for Hereditary Pancreatic Cancer Testing

Interventions

Saliva swab testing

Study Description

Brief Summary: The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only. Participants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test. Up to 3,000 participants will be enrolled in this study.

Detailed Description: